Skip to main content
. 2022 Oct 19;21:201. doi: 10.1186/s12943-022-01669-8

Table 3.

Multispecific CAR-T cell therapy in solid tumors

Condition Targeting
domain
Reference
HCC CD70/B7H3 [189, 414, 432434]
GPC3/CD147
c-MET/PD-L1

GPC3/ASGR1

gp100/HER2

Glioma CD70/B7H3 [189, 374376, 435, 436]
HER2/IL13Rα2
EGFRvIII/IL13Rα2 OR EphA2; MOG/IL13Rα2 OR EphA2
EGFRvIII/IL13Rα2 OR CD133
HER2/IL13Rα2/EphA2
IL13Rα2/ EphA2
GC Trop2/PD-L1 [277]
PC MSLN/CEA [437, 438]
MSLN/PSMA
EC CD70/B7H3 [189]
CRC

CD30/CEA;

CD30/TAG70

[439]
BC CD70/B7H3 [189, 414, 440442]
Her2/IGF1R
MUC1/HER2

ROR1/B7H3

gp100/HER2

PCa MSLN/PSMA [437]
LCa CD70/B7H3 [189, 204, 442]

ROR1/B7H3

PSCA/MUC1

OC FLOR1/MSLN [330, 333, 334]

ALPPL2/MCAM

ALPPL2/MSLN

ALPPL2/HER2

PD-L1/MUC16

MEL

CD70/B7H3

gp100/CSPG4

gp100/VEGFR-2

[189, 314, 443]